유전자 발현 분석 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 제품 유형별, 기술별, 용도별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)

Gene Expression Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Technique, By Application, By End User, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,165,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,535,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 10,960,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 유전자 발현 분석 시장은 2024년에 50억 2,000만 달러로 평가되었고, 2030년에는 78억 4,000만 달러에 이를 것으로 예측되며, 예측 기간 동안 CAGR 7.71%로 성장할 전망입니다.

이 시장은 생명과학 및 바이오기술 분야에서 중요한 역할을 수행하며, 다양한 생물학적 샘플에서 유전자 발현을 분석하는 도구와 기술을 제공합니다. 유전자 발현 분석은 약물 개발, 임상 진단, 맞춤형 의료, 학술 연구 등 다양한 분야에서 필수적인 기술로 자리 잡았습니다. 주요 성장 요인으로는 맞춤형 치료 접근법의 수요 증가가 꼽히며, 유전자 발현 프로파일링은 개인별 유전적 특성을 식별하여 더 정확하고 효과적인 치료법을 개발하는 데 기여합니다. 기술적 발전, 특히 RNA-Seq과 같은 고성능 시퀀싱 플랫폼의 발전은 연구자들이 전사체를 전례 없는 규모로 조사할 수 있는 능력을 크게 향상시켰습니다. 이러한 기술의 채택은 제약 기업, 진단 개발업체, 연구 기관 간의 협력을 촉진하며 생물의학 연구의 급속한 성장을 이끌고 있습니다. 암 분야에서는 유전자 발현 도구가 바이오마커 발견과 치료 반응 예측에 점점 더 많이 활용되면서 시장 확대가 가속화되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모(2024년)	50억 2,000만 달러
시장 규모(2030년)	78억 4,000만 달러
CAGR(2025-2030년)	7.71%
급성장 부문	RNA 발현
최대 시장	북미

시장 성장 촉진요인

시퀀싱 기술의 발전

주요 시장 과제

데이터 분석의 복잡성

주요 시장 동향

단일 세포 RNA 시퀀싱(scRNA-Seq)

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 유전자 발현 분석 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 제품 유형별(기기, 서비스, 기타)
  • 기술별(RNA 발현, 프로모터 분석, 단백질 발현 및 번역 후 발현, 기타)
  • 용도별(약물 개발, 임상 진단, 맞춤형 의료, 학술 연구, 기타)
  • 최종 사용자별(제약 회사, 생명공학 기업, 개발조사 수탁기관(CRO), 학술기관 및 정부연구기관 등)
  • 지역별
  • 기업별(2024년)
• 시장 맵
  • 제품 유형별
  • 기술별
  • 용도별
  • 최종 사용자별
  • 지역별

제5장 아시아태평양의 유전자 발현 분석 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 제품 유형별
  • 기술별
  • 용도별
  • 최종 사용자별
  • 국가별
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 호주
  • 일본
  • 한국

제6장 유럽의 유전자 발현 분석 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 스페인
  • 이탈리아
  • 영국

제7장 북미의 유전자 발현 분석 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제8장 남미의 유전자 발현 분석 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제9장 중동 및 아프리카의 유전자 발현 분석 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제10장 시장 역학

• 성장 촉진요인
• 과제

제11장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 합병과 인수

제12장 세계의 유전자 발현 분석 시장 : SWOT 분석

제13장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Merck KGaA
• Genscript Biotech Corporation
• Qiagen
• Bio-Rad Laboratories
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Agilent Technologies
• Lonza Group Ltd.
• New England Biolabs Inc

제15장 전략적 제안

제16장 기업 소개와 면책사항

HBR

영문 목차

영문목차

The Global Gene Expression Analysis Market was valued at USD 5.02 billion in 2024 and is projected to reach USD 7.84 billion by 2030, growing at a CAGR of 7.71% during the forecast period. This market plays a crucial role in the life sciences and biotechnology sectors, offering tools and technologies for analyzing gene expression in various biological samples. Gene expression analysis has become fundamental in applications ranging from drug discovery and clinical diagnostics to personalized medicine and academic research. A key growth factor is the rising demand for personalized treatment approaches, where gene expression profiling helps identify individual genetic signatures, enabling more precise and effective therapies. Technological advancements, particularly in high-throughput sequencing platforms like RNA-Seq, have significantly enhanced researchers' ability to investigate the transcriptome at an unprecedented scale. The adoption of these technologies has fueled a surge in biomedical research and collaboration among pharmaceutical firms, diagnostic developers, and research institutions. In oncology, gene expression tools are increasingly used to discover biomarkers and predict treatment responses, further accelerating the expansion of the market.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 5.02 Billion
Market Size 2030	USD 7.84 Billion
CAGR 2025-2030	7.71%
Fastest Growing Segment	RNA Expression
Largest Market	North America

Key Market Drivers

Advancements in Sequencing Technologies

Technological progress in sequencing has been a critical driver of the Global Gene Expression Analysis Market. Next-generation sequencing (NGS), in particular, has transformed gene expression studies by offering high-throughput capabilities, greater sensitivity, and cost efficiency. NGS enables the simultaneous examination of thousands of genes across numerous samples, providing deeper insights into gene activity and regulation. These capabilities have broadened the use of gene expression profiling in personalized medicine, disease diagnostics, and fundamental research. The launch of high-capacity sequencers like Illumina's NovaSeq X Series, which can process over 20,000 whole genomes annually, exemplifies how enhanced throughput and reduced costs are making transcriptome analysis more accessible and widespread. This technological evolution is reshaping genomic research and reinforcing the market's long-term growth trajectory.

Key Market Challenges

Data Analysis Complexities

One of the significant hurdles in the Global Gene Expression Analysis Market is the complexity involved in managing and interpreting large-scale gene expression data. High-throughput methods, such as RNA-Seq, generate vast volumes of data that require sophisticated bioinformatics tools and computational infrastructure for effective analysis. The necessity for robust data processing pipelines-from quality control and alignment to normalization and differential expression analysis-adds layers of technical difficulty. Missteps at any stage can lead to inaccurate conclusions, undermining research validity. Additionally, the requirement for high-performance computing resources and specialized data analytics expertise presents a cost and skill barrier for many institutions, especially smaller laboratories and emerging markets. Addressing these analytical challenges is vital for maximizing the utility and reliability of gene expression studies.

Key Market Trends

Single-Cell RNA Sequencing (scRNA-Seq)

A prominent trend in the Global Gene Expression Analysis Market is the growing use of Single-Cell RNA Sequencing (scRNA-Seq). This cutting-edge technique enables researchers to profile gene expression at the individual cell level, revealing cellular heterogeneity that is otherwise masked in bulk RNA analyses. scRNA-Seq is transforming areas such as cancer biology, immunology, neuroscience, and developmental biology by allowing precise characterization of rare cell types and cellular states. This capability is driving a deeper understanding of disease mechanisms, progression, and treatment resistance. The rise of scRNA-Seq reflects a broader shift toward high-resolution, data-rich research tools that support more accurate and personalized scientific discoveries.

Key Market Players

• Merck KGaA
• Genscript Biotech Corporation
• Qiagen
• Bio-Rad Laboratories
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Agilent Technologies
• Lonza Group Ltd.
• New England Biolabs Inc

Report Scope:

In this report, the Global Gene Expression Analysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gene Expression Analysis Market, By Product Type:

• Instruments
• Services
• Others

Gene Expression Analysis Market, By Technique:

• RNA Expression
• Promotor Analysis
• Protein Expression & Post Translational Modification Expression
• Others

Gene Expression Analysis Market, By Application:

• Drug Discovery and Development
• Clinical Diagnostics
• Biotechnology and Microbiology
• Others

Gene Expression Analysis Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic and Government Research Institutes
• Others

Gene Expression Analysis Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gene Expression Analysis Market.

Available Customizations:

Global Gene Expression Analysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Gene Expression Analysis Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product Type (Instruments, Services, Others)
  • 4.2.2. By Technique (RNA Expression, Promotor Analysis, Protein Expression & Post Translational Modification Expression, Others)
  • 4.2.3. By Application (Drug Discovery and Development, Clinical Diagnostics, Biotechnology and Microbiology, Others)
  • 4.2.4. By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Government Research Institutes, Others)
  • 4.2.5. By Region
  • 4.2.6. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Product Type
  • 4.3.2. By Technique
  • 4.3.3. By Application
  • 4.3.4. By End User
  • 4.3.5. By Region

5. Asia Pacific Gene Expression Analysis Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type
  • 5.2.2. By Technique
  • 5.2.3. By Application
  • 5.2.4. By End User
  • 5.2.5. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Gene Expression Analysis Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product Type
      • 5.3.1.2.2. By Technique
      • 5.3.1.2.3. By Application
      • 5.3.1.2.4. By End User
  • 5.3.2. India Gene Expression Analysis Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product Type
      • 5.3.2.2.2. By Technique
      • 5.3.2.2.3. By Application
      • 5.3.2.2.4. By End User
  • 5.3.3. Australia Gene Expression Analysis Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product Type
      • 5.3.3.2.2. By Technique
      • 5.3.3.2.3. By Application
      • 5.3.3.2.4. By End User
  • 5.3.4. Japan Gene Expression Analysis Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product Type
      • 5.3.4.2.2. By Technique
      • 5.3.4.2.3. By Application
      • 5.3.4.2.4. By End User
  • 5.3.5. South Korea Gene Expression Analysis Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product Type
      • 5.3.5.2.2. By Technique
      • 5.3.5.2.3. By Application
      • 5.3.5.2.4. By End User

6. Europe Gene Expression Analysis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Gene Expression Analysis Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Germany Gene Expression Analysis Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Spain Gene Expression Analysis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User
  • 6.3.4. Italy Gene Expression Analysis Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product Type
      • 6.3.4.2.2. By Technique
      • 6.3.4.2.3. By Application
      • 6.3.4.2.4. By End User
  • 6.3.5. United Kingdom Gene Expression Analysis Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product Type
      • 6.3.5.2.2. By Technique
      • 6.3.5.2.3. By Application
      • 6.3.5.2.4. By End User

7. North America Gene Expression Analysis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Technique
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Gene Expression Analysis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Mexico Gene Expression Analysis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. Canada Gene Expression Analysis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User

8. South America Gene Expression Analysis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Technique
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Gene Expression Analysis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. Argentina Gene Expression Analysis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Colombia Gene Expression Analysis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User

9. Middle East and Africa Gene Expression Analysis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Technique
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 5.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Gene Expression Analysis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Saudi Arabia Gene Expression Analysis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. UAE Gene Expression Analysis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Gene Expression Analysis Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Merck KGaA
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Genscript Biotech Corporation
• 14.3. Qiagen
• 14.4. Bio-Rad Laboratories
• 14.5. Takara Bio Inc.
• 14.6. Thermo Fisher Scientific, Inc.
• 14.7. Promega Corporation
• 14.8. Agilent Technologies
• 14.9. Lonza Group Ltd.
• 14.10. New England Biolabs Inc

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료